PKC-δ Isozyme gene silencing restores vascular function in diabetic rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 25, Issue 4, 2014, Pages 341-349

  Klymenko, Kateryna ^a   Novokhatska, Tetiana ^a   Kizub, Igor ^a   Parshikov, Alexander ^a   Dosenko, Viktor ^b   Soloviev, Anatoly ^a  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

Diabetes; Potassium channels; Protein kinase C; RNA interference; Vascular smooth muscle

Indexed keywords

KETAMINE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STREPTOZOCIN; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; GENE; GENE SILENCING; MALE; NONHUMAN; POTASSIUM CHANNELOPATHY; POTASSIUM CURRENT; PROTEIN KINASE C DELTA GENE; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASODILATATION;

EID: 84925455564     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2013-0147     Document Type: Article

References (51)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. J Am Med Assoc 2001;286:1195-200.
2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
3. Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004;44:397-405.
4. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, et al. Diabetes patients requiring glucoselowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008;117:1945-54.
5. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-6.
6. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-74.
7. 2+-activated potassium β1 channel subunit in retinal arteriolar smooth muscle. Circ Res 2007;100:703-11.
8. + channels in the coronary artery smooth muscle cells of Zucker diabetic fatty rats. Biophys J 2008;95:5165-77
9. Knock GA, Ward JP. Redox regulation of protein kinases as a modulator of vascular function. Antioxid Redox Signal 2011;15:1531-47.
10. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 2003;370:361-71.
11. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995;270:28495-8.
12. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology 2006;21:269-80.
13. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-67.
14. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-70.
15. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010;106:1319-31.
16. Giogi C, Agnoletto C, Baldini C, Bononi A, Bonora M, Marchi S, et al. Redox control of protein kinase C: cell and disease-specific aspects. Antioxid Redox Signal 2010;13:1051-85.
17. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005;43:289-330.
18. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859-66.
19. Morgan S, Yamanouchi D, Harberg C, Wang Q, Keller M, Si Y, et al. Elevated protein kinase C-δ contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory signaling. Arterioscler Thromb Vasc Biol 2012;32:2493-502.
20. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001;15:188-200.
21. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001;98:9742-7.
22. Toker A. Signalling through protein kinase C. Front Biosci 1998;3:D1134-47.
23. Dempsey EC, Newton AC, Mochley-Rosen D, Fields AP, Reyland ME, Insel PA, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000;279:L429-38.
24. Ohanian V, Ohanian J, Shaw L, Scarth S, Parker PJ, Heagerty AM. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res 1996;78:806-12.
25. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, et al. Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 2009;15:1298-306.
26. Kim YH, Kim YS, Park CH, Chung IY, Yoo JM, Kim JG, et al. Protein kinase C-δ mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway. Diabetes 2008;57:2181-90.
27. Ha H, Yu MR, Choi YJ, Lee HB. Activation of protein kinase c-δ and c-ε by oxidative stress in early diabetic rat kidney. Am J Kidney Dis 2001;38:S204-7.
28. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 2005;109:143-59.
29. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998;14:241-9.
30. Sud N, Wedgwood S, Black SM. Protein kinase C-δ regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generation. Am J Physiol Lung Cell Mol Physiol 2008;294:L582-91.
31. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001;88:E14-22.
32. Cosentino F, Eto M, Paolis P, Loo B, Bachschmid M, Ullrich V, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells role of protein kinase C and reactive oxygen species. Circulation 2003;107:1017-23.
33. Gao L, Mann GE. Vascular NAD (P) H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 2009;82:9-20.
34. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase C-β prevents impaired endotheliumdependent vasodilation caused by hyperglycemia in humans. Circ Res 2002;90:107-11.
35. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991;87:1643-8.
36. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.
37. Ca channels deficiency as a possible reason for radiation-induced vascular hypercontractility. Vasc Pharmacol 2012;56:142-9.
38. Novokhatska T, Soloviev A, Tishkin S, Boldyriev A, Ivanova I, Strelkov I, et al. Correction of vascular hypercontractility in spontaneously hypertensive rats using shRNAs-induced δ protein kinase C gene silencing. Eur J Pharmacol 2013;718:401-7.
39. + channel by cyclic AMP in cultured porcine coronary artery smooth muscle cells. Life Sci 1993;53:1129-35.
40. Schubert R, Noack T, Serebryakov VN. Protein kinase C reduces the KCa current of rat tail artery smooth muscle cells. Am J Physiol Cell Physiol 1999;276:C648-58.
41. Zhou X, Wulfsen I, Utku E, Sausbier U, Sausbier M, Wieland T, et al. Dual role of protein kinase C on BK channel regulation. Proc Natl Acad Sci USA 2010;107:8005-10.
42. + channels by high glucose. Circ Res 2006;99:607-16.
43. Rodriguez-Rodriguez R, Simonsen U. Measurement of nitric oxide and reactive oxygen species in the vascular wall. Curr Anal Chem 2012;8:1-10.
44. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD (P) H oxidase. J Am Soc Nephrol 2003;14:S227-32.
45. Bankers-Fulbright JL, Kita H, Gleich GJ, O'Grady SM. Regulation of human eosinophil NADPH oxidase activity: a central role for PKC ä. J Cell Physiol 2001;189:306-15.
46. Fontayne A, Dang PM, Gougerot-Pocidalo MA, El-Benna J. Phosphorylation of p47phox sites by PKC alpha, β II, δ, and ζ: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 2002;41:7743-50.
47. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11.
48. Sledz CA, Williams BR. RNA interference in biology and disease. Blood 2005;106:787-94.
49. Rondinone CM. Therapeutic potential of iRNA in metabolic diseases. BioTechniques 2006;40:S31-6.
50. Reddy LS, Sarojamma V, Ramakrishna V. RNAi in medicine: current and future perspectives. Biotechnol Mol Biol Rev 2006;1:103-14.
51. Uprichard SL. The therapeutic potential of RNA interference. FEBS Lett 2005;579:5996-6007.